Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
Open Access
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (2) , 163-168
- https://doi.org/10.1023/a:1008243606668
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancerAnnals of Oncology, 1996
- Quality of life Evaluation by the eortc Questionnaire Technique in Patients with Generalized Malignant Melanoma on ChemotherapyActa Oncologica, 1996
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995
- Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancerCancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- Chemotherapy of gastric cancerCancer Treatment Reviews, 1988
- Reporting results of cancer treatmentCancer, 1981
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980
- A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancerCancer, 1974